오스테오닉

226400KOSDAQ

62.3 / 100

Reference Date: 2026-09-08

Financial Score29.0 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Plunged 16.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Osteonic produces and sells medical devices (implants) made of metal or biocompatible materials, used for bone fixation, replacement, and adjustment in various body parts such as the skull, jaw, trauma sites, and joints. While metal-based products dominate sales, biocomposite materials are gaining increasing share.

Number of Employees

197people

Average Salary

41.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.32Industry Average 15.005.0Point

In line with industry avg

PBR

1.29Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

11.82Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

19.29Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20259.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲27.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲35.5% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 10.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
오스테오닉, 상반기 매출액 261억원, 영업이익 48억원, 당기순이익 ...
오스테오닉의 상반기 실적이 작년 동기 대비 매출과 영업이익이 각각 27.2%, 12.0% 증가하며 당기순이익은 152.6% 상승, 신규 라인업과 미국 시장 확대에 따른 중장기 성장 전망으로 긍정적.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 4,235Won52-week high 8,14052-week low 3,745

1-month return0.0Point

1m -16.47% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-09-04
Neutral반기보고서 (2026.06)2026-08-14